eISSN: 1897-4295
ISSN: 1734-9338
Advances in Interventional Cardiology/Postępy w Kardiologii Interwencyjnej
Current issue Archive Manuscripts accepted About the journal Abstracting and indexing Subscription Contact Instructions for authors
SCImago Journal & Country Rank
vol. 14
Original paper

Increased risk profile in the treatment of patients with symptomatic degenerative aortic valve stenosis over the last 10 years

Jakub Baran, Jakub Podolec, Marek T. Tomala, Bartłomiej Nawrotek, Łukasz Niewiara, Andrzej Gackowski, Tadeusz Przewłocki, Krzysztof Żmudka, Anna Kabłak-Ziembicka

Adv Interv Cardiol 2018; 14, 3 (53): 276–284
Online publish date: 2018/09/21
View full text
Get citation
JabRef, Mendeley
Papers, Reference Manager, RefWorks, Zotero
Currently, Cardiology Centres are overfilled with patients with degenerative aortic valve stenosis (DAS), usually eldery, with severe concommittant comorbidities, who are referred for further decisions and possible intervention.

To evaluate changes in the risk profile of patients with severe DAS admitted to the cardiology department a decade ago compared with patients currently being admitted.

Material and methods
We retrospectively evaluated all patients admitted with confirmed severe DAS, hospitalized during 2005–2006 (group I: 140 patients) and in 2016 (group II: 152 patients), admitted for aortic valve intervention. A standard transthoracic echocardiogram, cardiovascular symptom and risk factor distribution, perioperative risk with the logistic EuroSCORE II and STS mortality scores were obtained.

Patients in group II were significantly older (p < 0.001), had more cardiovascular risk factors, and more often presented with atrial fibrillation (27% vs. 11.4%, p = 0.001), renal impairment (34.9% vs. 22.8%; p = 0.024), severe lung disease (17.1% vs. 2.1%, p < 0.001), and extracardiac arteriopathy (40.1% vs. 17.8%, p < 0.001). The aortic valve area (AVA) (p = 0.356), mean-transvalvular pressure gradient (p = 0.215), and left ventricular ejection fraction (p = 0.768) were similar in both groups. However, the prevalence of pulmonary hypertension, severe mitral regurgitation, and low-flow, low-gradient DAS were 3.1-, 8.4- and 1.84-fold more frequent in group II than group I. The percentages of subjects with EuroSCORE II and STS scores ≥ 4% in 2005–2006 were 7.1% and 6.4%, as compared to 27% and 26.3% in 2016 (both p < 0.001). 22% of patients in 2016, as compared to 31% in 2005/2006, were considered ineligible for DAS intervention.

In just a decade, the risk profile of patients admitted with DAS has increased hugely, mainly due to older age, accumulation of comorbidities and more advanced disease at presentation. Although transcatheter aortic valve intervention has expanded the indications for intervention in high-risk patients, the number of patients disqualified from interventional treatment remains high.


degenerative aortic valve stenosis, transcatheter aortic valve intervention, aortic valve replacement, risk assessment, EuroSCORE II, STS score

Eveborn GW, Schirmer H, Heggelund G, et al. The evolving epidemiology of valvular aortic stenosis. The Tromsø Study. Heart 2013; 99: 396-400.
Nkomo VT, Gardin JM, Skelton TN. Burden of valvular heart diseases: a population based study. Lancet 2006; 368: 1005-11.
Vahanian A, Alfieri O, Andreotti F, et al. Guidelines on the management of valvular heart disease (version 2012): The Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology (ESC) and the European Association for Cardio Thoracic Surgery (EACTS). Eur Heart J 2012; 33: 2451-96.
Ramos J, Monteagudo JM, González-Alujas T, et al. Large-scale assessment of aortic stenosis: facing the next cardiac epidemic? Eur Heart J Cardiovasc Imaging 2017; doi: 10.1093/ehjci/jex223.
Iung B, Vahanian A. Degenerative calcific aortic stenosis: a natural history. Heart 2012; 98 Suppl 4: iv7-13.
Danielsen R, Aspelund T, Harris TB, et al. The prevalence of aortic stenosis in the elderly in Iceland and predictions for the coming decades: the AGES-Reykjavik study. Int J Cardiol 2014; 176: 916-22.
Tastet L, Simard L, Clavel MA. Severe and asymptomatic aortic stenosis management challenge: knowing that we do not really know. Curr Treat Options Cardiovasc Med 2017; 19: 33.
Pohle K, Mäffert R, Ropers D, et al. Progression of aortic valve calcification: association with coronary atherosclerosis and cardiovascular risk factors. Circulation 2001; 104: 1927-32.
Peeters F, Meex S, Dweck MR, et al. Calcific aortic valve stenosis: hard disease in the heart: a biomolecular approach towards diagnosis and treatment. Eur Heart J 2018; 39: 2618-24.
Généreux P, Pibarot P, Redfors B, et al. Staging classification of aortic stenosis based on the extent of cardiac damage. Eur Heart J 2017; 38: 3351-8.
Baumgartner H, Falk V, Bax J, et al. Guidelines for the management of valvular heart disease. Kardiol Pol 2018; 76: 1-62.
Nashef SAM, Roques F, Sharples LD, et al. EuroSCORE II. Eur J Cardiothorac Surg 2012; 41: 734-44.
O’Brien SM, Shahian DM, Filardo G, et al. The Society of Thoracic Surgeons 2008 cardiac surgery risk models: part 2 – isolated valve surgery. Ann Thorac Surg 2009; 88: S23-42.
Shahian DM, O’Brien SM, Filardo G, et al. The Society of Thoracic Surgeons 2008 cardiac surgery risk models: part 3 – valve plus coronary artery bypass grafting surgery. Ann Thorac Surg 2009; 88: S43-62.
Taniguchi T, Morimoto T, Shiomi H, et al. Prognostic impact of left ventricular ejection fraction in patients with severe aortic stenosis. JACC Cardiovasc Interv 2018; 11: 145-57.
Baumgartner H, Hung J, Bermejo J, et al. Recommendations on the echocardiographic assessment of aortic valve stenosis: a focused update from the European Association of Cardiovascular Imaging and the American Society of Echocardiography. J Am Soc Echocardiogr 2017; 30: 372-92.
Podolec J, Baran J, Niewiara Ł, et al. The role of biomarkers as an alternative and completion of the diagnostic and therapeutic pathway in patients with aortic stenosis. J Rare Card Dis 2016; 2: 1–1.
Bluth EI, Stavros AT, Marich KW, et al. Carotid Duplex sonography: a multicenter recommendation for standardized imaging and Doppler criteria. Radiographics 1988; 8: 487-506.
Kablak-Ziembicka A, Przewlocki T, Tracz W, et al. Prognostic value of carotid intima-media thickness in detection of coronary atherosclerosis in patients with calcified aortic valve stenosis. J Ultrasound Med 2005; 24: 461-7.
Kabłak-Ziembicka A, Przewłocki T, Hlawaty M, et al. Internal carotid artery stenosis in patients with degenerative aortic stenosis. Kardiol Pol 2008; 66: 837-42.
Levy F, Bohbot Y, Sanhadji K, et al. Impact of pulmonary hypertension on long-term outcome in patients with severe aortic stenosis. Eur Heart J Cardiovasc Imaging 2018; 19: 553-61.
Genereux P, Stone GW, O’Gara PT, et al. Natural history, diagnostic approaches, and therapeutic strategies for patients with asymptomatic severe aortic stenosis. J Am Coll Cardiol 2016; 67: 2263-88.
Das P, Rimington H, Chambers J. Exercise testing to stratify risk in aortic stenosis. Eur Heart J 2005; 26: 1309-13.
Maréchaux S, Hachicha Z, Bellouin A, et al. Usefulness of exercise-stress echocardiography for risk stratification of true asymptomatic patients with aortic valve stenosis. Eur Heart J 2010; 31: 1390-7.
Pellikka PA, Sarano ME, Nishimura RA, et al. Outcome of 622 adults with asymptomatic, hemodynamically significant aortic stenosis during prolonged follow-up. Circulation 2005; 111: 3290-5.
Iung B, Baron G, Butchart EG, et al. A prospective survey of patients with valvular heart disease in Europe: the Euro Heart Survey on Valvular Heart Disease. Eur Heart J 2003; 24: 1231-43.
Bonow RO, Greenland P. Population wide trends in aortic stenosis incidence and outcomes. Circulation 2015; 131: 969-71.
Bobrowska B, Zasada W, Dziewierz A, et al. Comparison of demographics, cardiovascular risk factors profile and prevalence of coexistent atherosclerotic vascular disease in patients with severe aortic stenosis stratified according to dichotomized stenosis severity. Adv Interv Cardiol 2017; 13: 331-4.
Berry C, Lloyd SM, Wang Y, et al. The changing course of aortic valve disease in Scotland: temporal trends in hospitalizations and mortality and prognostic importance of aortic stenosis. Eur Heart J 2013; 34: 1538-47.
Minamino-Muta E, Kato T, Morimoto T, et al. Causes of death in patients with severe aortic stenosis: an observational study. Sci Rep 2017; 7: 14723.
Ben-Dor I, Pichard AD, Gonzalez MA, et al. Correlates and causes of death in patients with severe symptomatic aortic stenosis who are not eligible to participate in a clinical trial of transcatheter aortic valve implantation. Circulation 2010; 122: 37-42.
Thyregod HG, Steinbruchel DA, Ihlemann N, et al. Transcatheter versus surgical aortic valve replacement in patients with severe aortic valve stenosis: 1-year results from the All-Comers NOTION randomized clinical trial. J Am Coll Cardiol 2015; 65: 2184-94.
Witberg G, Lador A, Yahav D, Kornowski R. Transcatheter versus surgical aortic valve replacement in patients at low surgical risk: a meta-analysis of randomized trials and propensity score matched observational studies. Catheter Cardiovasc Interv 2018 Feb 1 Epub ahead of print; doi: 10.1002/ccd.27518.
Khan SU, Lone AN, Saleem MA, et al. Transcatheter vs surgical aortic-valve replacement in low- to intermediate-surgical-risk candidates: a meta-analysis and systematic review. Clin Cardiol 2017; 40: 974-81.
Parma R, Dąbrowski M, Ochała A, et al. The Polish Interventional Cardiology TAVI Survey (PICTS): adoption and practice of transcatheter aortic valve implantation in Poland. Adv Interv Cardiol 2017; 13: 10-7.
Quick links
© 2019 Termedia Sp. z o.o. All rights reserved.
Developed by Bentus.
PayU - płatności internetowe